# Regeneron Pharmaceuticals (stock symbol: REGN) Logo in transparent PNG and SVG formats

## Regeneron Pharmaceuticals Logo large

### Regeneron Pharmaceuticals Logo large Download PNG (19 KB)

![Regeneron Pharmaceuticals Logo large Download PNG (19 KB)](/img/orig/REGN_BIG-e85f1041.png)

### Regeneron Pharmaceuticals Logo large Download SVG (2.64 KB)

![Regeneron Pharmaceuticals Logo large Download SVG (2.64 KB)](/img/orig/REGN_BIG-7bb2d8f9.svg)

## Regeneron Pharmaceuticals Logo icon format

### Regeneron Pharmaceuticals Logo icon format Download PNG (26.6 KB)

![Regeneron Pharmaceuticals Logo icon format Download PNG (26.6 KB)](/img/orig/REGN-ab83b73e.png)

### Regeneron Pharmaceuticals Logo icon format Download SVG (663 Bytes)

![Regeneron Pharmaceuticals Logo icon format Download SVG (663 Bytes)](/img/orig/REGN-e6875779.svg)

## Regeneron Pharmaceuticals Logo large for dark backgrounds

### Regeneron Pharmaceuticals Logo large for dark backgrounds Download PNG (19 KB)

![Regeneron Pharmaceuticals Logo large for dark backgrounds Download PNG (19 KB)](/img/orig/REGN_BIG.D-aefdc480.png)

### Regeneron Pharmaceuticals Logo large for dark backgrounds Download SVG (2.64 KB)

![Regeneron Pharmaceuticals Logo large for dark backgrounds Download SVG (2.64 KB)](/img/orig/REGN_BIG.D-c6455b47.svg)

## Regeneron Pharmaceuticals Logo icon format for dark backgrounds

### Regeneron Pharmaceuticals Logo icon format for dark backgrounds Download PNG (26.6 KB)

![Regeneron Pharmaceuticals Logo icon format for dark backgrounds Download PNG (26.6 KB)](/img/orig/REGN.D-04ce7b62.png)

### Regeneron Pharmaceuticals Logo icon format for dark backgrounds Download SVG (663 Bytes)

![Regeneron Pharmaceuticals Logo icon format for dark backgrounds Download SVG (663 Bytes)](/img/orig/REGN.D-49d70be7.svg)

## About Regeneron Pharmaceuticals

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat neovascular age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration and license agreements with Sanofi; Bayer; Teva Pharmaceutical Industries Ltd.; Mitsubishi Tanabe Pharma Corporation; Alnylam Pharmaceuticals, Inc.; Roche Pharmaceuticals; and Kiniksa Pharmaceuticals, Ltd., as well as has an agreement with the U.S. Department of Health and Human Services, as well as with Zai Lab Limited; Intellia Therapeutics, Inc.; Biomedical Advanced Research Development Authority; and AstraZeneca PLC. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.

1. Website domain: regeneron.com
2. Employees: 11851
3. Marketcap: $87.96 Billion USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
